THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM

The PCCTC was formed to address critically unmet needs in prostate cancer. Our mission is to design, implement, and complete early-phase process driven clinical trials, translating scientific discoveries to improved standards of care.

Learn More +

The PCCTC is changing how prostate cancer drugs are developed. Our unique infrastructure facilitates project co-development between investigators, clinical research sites and industry partners.

View Our Services

Expertise

Internationally recognized leaders in the field, PCCTC investigators come from the nation’s top academic medical centers where they are actively engaged in world class science through cutting-edge translational prostate cancer research.

Our Participating Clinical Research Sites

Recent News +++

Bipolar Androgen Therapy for Patients Who Have Progressed on Abiraterone

Media Relations by PCCTC February 26, 2021

Led by Dr. Samuel R. Denmeade and his team at Johns Hopkins School of Medicine – Sid...

Learn More

PCCTC Germline Genetics Working Group Publishes New Guidelines

Press Releases by PCCTC September 30, 2020

Practical considerations and challenges for germline genetic testing in patients with pros...

Learn More

PCCTC Investigators on the Diversity of Enrollment in Prostate Cancer Clinical Trials

Press Releases by AACR June 5, 2020

“Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Futu...

Learn More

The Transformative Development and Progress of the PCCTC

Press Releases by UroToday May 12, 2020

Dr. Charles Ryan (University of Minnesota) is joined by the PCCTC’s CEO, Jake Vinson...

Learn More

The PCCTC: Addressing Health Disparities by Increasing Diversity in Clinical Trials

Press Releases by CDMRP April 22, 2020

A commitment to addressing prostate cancer health disparities.

Learn More
View More News +

Follow Us

On National #NursesDay we honor the dedicated healthcare professionals who accelerate clinical research, advance pa… https://t.co/ELIOfJcCPC
RT @urotoday: #TRANSFORMER a study comparing bipolar androgen therapy vs enzalutamide in #mCRPC. @EAntonarakis @hopkinskimmel joins @charle…
#ASCO21 Plenary Session with PCCTC Medical Director @morr316: Phase III study of lutetium-177-PSMA-617 in patients… https://t.co/oBPOVD5ZIW

Join our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…

2018-23944 Clinical Data Manager, Prostate Cancer Clinical Trials Consortium (PCCTC) | Memorial Sloan Kettering Cancer Center Careers

careers.mskcc.org

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.